Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Level of Branded Generic Apixaban in Patients with Atrial Fibrillation
TCTR20230410004Phase 4Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by Faculty of Medicine, Chiang Mai University. Started Apr 2023; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20230410004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230410004.